Igrene (ABI) Q1 25/26 earnings summary

Executive summary

• Focus on developing technology to convert leaking biogenic methane in Siljansringen into hydrogen and carbon using energy-efficient, CO2-free cold pyrolysis in partnership with SEID AS.

• No revenues reported for the quarter; operations are pre-commercial and focused on R&D and demonstration projects.

• Strategic shift driven by Swedish legal restrictions on natural gas extraction, with emphasis on environmental benefits and market potential for hydrogen and carbon.

Financial highlights

• Operating result for the quarter: –1,748 KSEK (improved from –2,551 KSEK year-over-year).

• Result after financial items: –1,663 KSEK (–2,551 KSEK year-over-year).

• Earnings per share: –0.01 SEK (–0.02 SEK year-over-year).

• No operating income; total costs for the quarter were 1,748 KSEK, mainly for ongoing operations.

• Depreciation for the quarter: 0 KSEK (38 KSEK year-over-year).

Outlook and guidance

• Awaiting potential legislative changes to allow methane extraction; current focus is on technology development and demonstration.

• Market potential for both the technology and the end products (hydrogen and carbon) is considered significant, especially given the modularity and scalability of the process.